Structural and functional changes in the kidneys and their effect on cardiovascular risk in elderly patients
Like other organ systems, the kidneys also go through process of normal senescence, including both anatomical and physiological changes. Normal physiological aging is characterized by the expected age-related changes in the kidneys. With age, the kidneys are subject to structural changes, for example, there is a decrease in the number of functional glomeruli due to an increase in the prevalence of nephrosclerosis (atherosclerosis, glomerulosclerosis, atrophy of the tubules with interstitial fibrosis) and to some extent compensatory hypertrophy of the remaining nephrons. Older age is also associated with reduced cortical volume, increased medullary, and larger and more numerous renal cysts. Changes in normal aging are important in clinical practice. Against the background of suppression of reparative capabilities, the elderly are more prone to acute damage and chronic kidney disease, aggravation of the course of chronic kidney disease. The elderly have less renal functional reserve when they do actually develop chronic kidney disease and they are also at higher risk for acute kidney injury. Cardiovascular disease is a leading cause of death and a common comorbidity among patients with kidney disease. In this review, we have identified the most characteristic structural and functional changes in the kidneys in elderly patients and their impact on cardiovascular risk.
Golovina N.I., Lykov Yu.A. 2020. Structural and functional changes in the kidneys and their effect on cardiovascular risk in elderly patients. Challenges in Modern Medicine, 43 (4): 539–548 (in Russian). DOI: 10.18413/2687-0940-2020-43-4-539-548
While nobody left any comments to this publication.
You can be first.
Moiseev V.S., Muhin N.A., Smirnov A.V., Kobalava Zh.D., Bobkova I.N., Villeval'de S.V., Efremovceva M.A., Kozlovskaya L.V., Shvecov M.Yu., Shestakova M.V., Arutyunov G.P., Bojcov S.A., Galyavich A.S., Grinshtejn Yu.I., Dobronravov V.A., Drapkina O.M., Ermolenko V.M., Karpov Yu.A., Kayukov I.G., Kotovskaya Yu.V., Kuharchuk V.V., Martynov A.I., Morozova T.E., Oganov R.G., Podzolkov V.I., Rozhinskaya L.Ya., Tereshchenko S.N., Fomin V.V., Hirmanov V.N., Chazova I.E., Shamhalova M.Sh., Shilov E.M., Shlyahto E.V., Shutov A.M. 2014. Serdechno-sosudistyj risk i hronicheskaya bolezn' pochek: strategii kardio-nefroprotekcii [Cardiovascular risk and chronic kidney disease: strategies for cardio-nephroprotection]. Rossijskij kardiologicheskij zhurnal. (8): 7–37. doi: 10.15829/1560-4071-2014-8-7-37 (in Russian).
Osipova O.A., Gosteva E.V., Chefranova Zh.Yu., Zhernakova N.I., Lykov Yu.A., Avdeeva I.V. 2020. Vliyanie farmakoterapii na dinamiku markerov obmena kollagena u bol'nyh hronicheskoj serdechnoj nedostatochnost'yu s promezhutochnoj frakciej vybrosa na fone ishemicheskoj bolezni serdca v starshih vozrastnyh gruppah [The influence of pharmacotherapy on the dynamics of collagen metabolism markers in patients with chronic heart failure with intermediate ejection fraction against the background of coronary heart disease in older age groups]. Kardiovaskulyarnaya terapiya i profilaktika. 19 (5): 188–194 (in Russian).
Osipova O.A., Nagibina A.I., Komisov A.A., Petrova G.D., Shekhovcova L.V., Vlasenko M.A., Vlasenko O.A. 2016. Patomorfologicheskie mekhanizmy regulyacii obrazovaniya miokardial'nogo fibroza u bol'nyh hronicheskoj serdechnoj nedostatochnost'yu na fone ishemicheskoj bolezni serdca [Pathomorphological mechanisms of regulation of myocardial fibrosis formation in patients with chronic heart failure on the background of ischemic heart disease]. Zhurnal serdechnaya nedostatochnost'. 5 (98): 357–364 (in Russian).
Sviridova M.S., Efremova O.A., Kamyshnikova L.A. 2013. Rasprostranennost' hronicheskoj bolezni pochek I–III stadij v Belgorodskoj oblasti [Prevalence of Stage I–III Chronic Kidney Disease in the Belgorod Region]. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Medicina. Farmaciya. 4 (147): 182–186 (in Russian).
Abdulkader R.C.R.M., Burdmann E.A., Lebrão M.L., Duarte Y.A.O., Zanetta D.M.T. 2017. Dec 19. Aging and decreased glomerular filtration rate: An elderly population-based study. PLoS One.; 12 (12): e0189935. doi: 10.1371/journal.pone.0189935.
Chagnac A., Zingerman B., Rozen-Zvi B., Herman-Edelstein M. 2019. Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity. Nephron. 143 (1): 38–42. doi: 10.1159/000499486.
Charlton J.R., Xu Y., Wu T., deRonde K.A., Hughes J.L., Dutta S., Oxley G.T., Cwiek A., Cathro H.P., Charlton N.P., Conaway M.R., Baldelomar E.J., Parvin N., Bennett K.M. 2020. Sep 8. Magnetic resonance imaging accurately tracks kidney pathology and heterogeneity in the transition from acute kidney injury to chronic kidney disease. Kidney Int.: S0085–2538 (20) 31045–0. doi: 10.1016/j.kint.2020.08.021.
Chevalier R.L. 2019 Jul. Evolution, kidney development, and chronic kidney disease. Semin Cell. Dev. Biol. 91: 119–131. doi: 10.1016/j.semcdb.2018.05.024.
Denic A., Alexander M.P., Kaushik V., Lerman L.O., Lieske J.C., Stegall M.D., Larson J.J., Kremers W.K., Vrtiska T.J., Chakkera H.A., Poggio E.D., Rule A.D. 2016. Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults. Am. J. Kidney Dis. 68 (1): 58–67. doi: 10.1053/j.ajkd.2015.12.029.
Denic A., Glassock R.J., Rule A.D. 2016. Structural and Functional Changes With the Aging Kidney Adv. Chronic. Kidney. Dis. 23 (1): 19–28. doi: 10.1053/j.ackd.2015.08.004.
Denic A., Lieske J.C., Chakkera H.A., Poggio E.D., Alexander M.P., Singh P., Kremers W.K., Lerman L.O., Rule A.D. 2017. The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. J. Am. Soc. Nephrol. 28 (1): 313–320. doi: 10.1681/ASN.2016020154.
Elsherbiny H.E., Alexander M.P., Kremers W.K., Park W.D., Poggio E.D., Prieto M., Lieske J.C., Rule A.D. 2014. Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. Clin. J. Am. Soc. Nephrol. 9 (11): 1892–902. doi: 10.2215/CJN.02560314.
Glassock R., Denic A., Rule A.D. 2017. When kidneys get old: an essay on nephrogeriatrics. J. Bras. Nefrol. 39 (1): 59–64. Portuguese, English. doi: 10.5935/0101-2800.20170010.
Glassock R.J., Rule A.D. 2016. Aging and the Kidneys: Anatomy, Physiology and Consequences for Defining Chronic Kidney Disease. Nephron. 134 (1): 25–9. doi: 10.1159/000445450.
Hodgin J.B., Bitzer M., Wickman L., Afshinnia F., Wang S.Q., O'Connor C., Yang Y., Meadowbrooke C., Chowdhury M., Kikuchi M., Wiggins J.E., Wiggins R.C. 2015. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective. J. Am. Soc. Nephrol. 26 (12): 3162–78. doi: 10.1681/ASN.2014080752.
Hommos M.S., Glassock R.J., Rule A.D. 2017. Structural and Functional Changes in Human Kidneys with Healthy Aging. J. Am. Soc. Nephrol. 28 (10): 2838–2844. doi: 10.1681/ASN.2017040421.
Hughson M.D., Hoy W.E., Bertram J.F. 2020. Progressive Nephron Loss in Aging Kidneys: Clinical-Structural Associations Investigated by Two Anatomical Methods. Anat. Rec. (Hoboken). 303 (10): 2526–2536. doi: 10.1002/ar.24249.
Humphreys B.D. 2018. Mechanisms of Renal Fibrosis. Annu. Rev. Physiol. 10; 80: 309–326. doi: 10.1146/annurev-physiol-022516-034227.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2017 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter., Suppl. 2013; 3: 1–150.
O'Sullivan E.D., Hughes J., Ferenbach D.A. 2017. Renal Aging: Causes and Consequences. J. Am. Soc. Nephrol. 28 (2): 407–420. doi: 10.1681/ASN.2015121308.
Okabayashi Y., Tsuboi N., Kanzaki G., Sasaki T., Haruhara K., Koike K., Takahashi H., Ikegami M., Shimizu A., Yokoo T. Aging Vs. 2019. Hypertension: An Autopsy Study of Sclerotic Renal Histopathological Lesions in Adults With Normal Renal Function. Am. J. Hypertens. 11; 32 (7): 676–683. doi: 10.1093/ajh/hpz040.
Osipova O.A., Gosteva E.V., Shepel R.N., Belousova О.N., Tsurikova L.V., Petrichko T.A. 2020. Study of the role of oxidative stress, antioxidant protection and immune inflammation markers in the pathogenesis of chronic heart failure by the middle range ejection fraction in elderly patients depending on gender. Journal of critical reviews (JCR). 7 (15): 14–21.
Ozdemir A.A., Kapucu K. 2017. The relationship between simple renal cysts and glomerular filtration rate in the elderly. Int. Urol. Nephrol. 49 (2): 313–317. doi: 10.1007/s11255-016-1414-9.
Russo G.T., De Cosmo S., Viazzi F., Mirijello A., Ceriello A., Guida P., Giorda C., Cucinotta D., Pontremoli R., Fioretto P. 2018. AMD-Annals Study Group. Diabetic kidney disease in the elderly: prevalence and clinical correlates. BMC Geriatr. 18 (1): 38. doi: 10.1186/s12877-018-0732-4.
Schmitt R., Melk A. 2017. Molecular mechanisms of renal aging. Kidney Int. 92 (3): 569–579. doi: 10.1016/j.kint.2017.02.036.
Tan J.C., Busque S., Workeneh B., Ho B., Derby G., Blouch K.L., Sommer F.G., Edwards B., Myers B.D. 2010. Effects of aging on glomerular function and number in living kidney donors. Kidney Int. 78 (7): 686–92. doi.org/10.1038/ki.2010.128.